EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Clinical Utility of 68 Ga‐DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report

Yuta Mine, Toru Sakatani, Sho Koyasu, Takashi Ogata, Yuki Teramoto iD, Akio Sakamoto iD, Takashi Mizowaki, Yuji Nakamoto, Takashi Kobayashi iD, Takayuki Goto

IJU Case Reports · 2026-07 · 9 (4)

DOI: 10.1002/iju5.70210 ↗

Kurz gefasst

Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 10.06.2026. Verfasst von Yuta Mine und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Kyoto University Hospital Kyoto Japan. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

68 Ga‐DOTATOC positron emission tomography/computed tomography (PET/CT) targets somatostatin receptors (SSTRs) and is an established molecular imaging modality for neuroendocrine tumors (NETs). Although SSTR expression has been reported in renal cell carcinoma (RCC), its clinical utility remains unclear. Case Presentation A 76‐year‐old woman who had undergone open partial nephrectomy for clear cell RCC (grade 2, pT1bN0M0) 3 years before developed a sternal metastasis, which was surgically resected with negative margins. Nine months later, follow‐up CT revealed a soft‐tissue lesion posterior to the sternum. 68 Ga‐DOTATOC PET/CT showed no uptake in this lesion but intense uptake at the Th8 vertebra, indicating metastasis. After stereotactic body radiation therapy (35 Gy in five fractions), persistent uptake was observed 8 months later, suggesting residual viable tumor, which was histopathologically confirmed after resection.

Conclusion

68 Ga‐DOTATOC PET/CT was useful in evaluating the possibility of recurrence of the soft‐tissue lesion, assessing post‐radiation viability, and guiding treatment in RCC.

Schlagwörter

Stichwörter der Autor:innen

neoplasm metastasisoctreotidepositron emission tomography computed tomographyrenal cell carcinomasomatostatin receptors

Autor:innen und Institutionen

  • Department of Urology Kyoto University Hospital Kyoto Japan.
  • Department of Diagnostic Imaging and Nuclear Medicine Kyoto University Hospital Kyoto Japan.
  • Department of Radiation Therapy Kyoto University Hospital Kyoto Japan.
  • Department of Diagnostic Pathology Kyoto University Hospital Kyoto Japan.
  • Department of Orthopaedic Surgery Kyoto University Hospital Kyoto Japan.

ORCID-Profile: Yuki Teramoto, Akio Sakamoto, Takashi Kobayashi

Zitieren

APA

Mine, Y., Sakatani, T., Koyasu, S., Ogata, T., Teramoto, Y., Sakamoto, A., Mizowaki, T., Nakamoto, Y., Kobayashi, T., & Goto, T. (2026). Clinical Utility of 68 Ga‐DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report. IJU Case Reports, 9(4). https://doi.org/10.1002/iju5.70210

Vancouver

Mine Y, Sakatani T, Koyasu S, Ogata T, Teramoto Y, Sakamoto A, et al. Clinical Utility of 68 Ga‐DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report. IJU Case Reports. 2026;9(4). doi:10.1002/iju5.70210

BibTeX
@article{Mine2026,
  author = {Mine, Yuta and Sakatani, Toru and Koyasu, Sho and Ogata, Takashi and Teramoto, Yuki and Sakamoto, Akio and Mizowaki, Takashi and Nakamoto, Yuji and Kobayashi, Takashi and Goto, Takayuki},
  title = {Clinical Utility of 68 Ga‐DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report},
  journal = {IJU Case Reports},
  year = {2026},
  volume = {9},
  number = {4},
  doi = {10.1002/iju5.70210}
}
Kostenlos starten →